問卷

TPIDB > Principal Investigator

Principal Investigator


China Medical University Hospital

Division of Dermatology

更新時間:2025-12-01

方心禹
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

1Cases

2025-08-01 - 2027-04-09

Phase II

Active
A Phase 2 Study to Evaluate the Safety, Tolerability, and Clinical Activity of BLU-808, a Wild Type KIT Inhibitor, in Chronic Inducible Urticaria and Chronic Spontaneous Urticaria
  • Condition/Disease

    Chronic Inducible Urticaria and Chronic Spontaneous Urticaria

  • Test Drug

    tablet

Participate Sites
6Sites

Recruiting6Sites